Trent Wang, MD
Curious about CAR T-cell therapy? We went straight to the source for answers.
In this episode, the LLS Patient Education team visited The University of Miami Sylvester Cancer Center to meet with Dr. Trent Wang. He answered some of the most frequently asked questions from our patients and caregivers about this innovative cancer treatment – from who’s eligible and what to expect, to side effects, caregiver roles, and exciting future developments.
Podcast: Play in new window | Download
Subscribe: Spotify | Pandora | Blubrry | JioSaavn | Podchaser | More
CLICK HERE to participate in our episode survey.Mentioned on this episode:
- CAR T-cell therapy
- Stem cell transplantation
- Graft-vs-host disease (GVHD)
- LLS Clinical Trial Support Center
- Bispecific antibodies – Immunotherapy fact sheet
Additional LLS Support Resources:
- Free Nutrition Consultations
- Information Specialists
- Financial support
- Free telephone/web patient programs
- Free booklets
- Young Adult Resources
- Online chats
- Support groups
- Caregiver support
- Caregiver Workbook
- Advocacy and Public Policy
- Survivorship Workbook
- LLS Community
- Mental Health Resources
Supported by Bristol Myers Squibb; Johnson & Johnson & Legend Biotech; and Kite, a Gilead Company.
Great!
Great interview. I learned so much. My son has Mantle Cell Lymphoma. Currently being treated with a BTK inhibitor
This was a great podcast. I had my CAR-T treatment 2 years ago and the last 6 months my IgG numbers plummeted and now I understand why. After my CAR-T I experienced both CRS and iCans. My experience was very much like what Dr Wang described here. During the discussion about caregivers, I would have included the prohibition of driving for 8 weeks, that’s significant. Thank you for this!
I have lymphoma non Hodgkin large B cell. This is my second round of this cancer. I got my CAR T infusion in January 2025. I was very lucky, I had zero bad effects from the infusion. I am home now, had a Pet scan a couple weeks ago and it showed my SUV at 1.6. My labs have all been very good so I’m excited about the future.